"I was born in Timisoara, Romania and grew up in Toronto. I earned my bachelors degree from Princeton University, where I majored in Ecology and Evolutionary Biology. I then worked as a Research Technician in a signal transduction lab at Memorial Sloan Kettering Cancer Center, where I explored changes in radiosensitivity conferred by knocking out different repair pathways. I went on to earn my medical degree, as well as my masters in public health, from SUNY Downstate College of Medicine, where I was elected to Alpha Omega Alpha. During my time at Downstate, I was involved in radiation oncology clinical research, focusing on the treatment of gastrointestinal malignancies. I then completed my transitional year internship at Memorial Sloan Kettering Cancer Center."
Julie DR and Goodman KA. Advances in the Management of Anal Cancer. Curr Oncol Rep. 2016;18(3):20.
Julie DAR, Oh JH, Aditya AP, Tom A, Wu AJ, Goodman KA. Predictors of acute toxicities during chemoradiation using intensity-modulated radiotherapy for anal squamous cell carcinoma. Acta Oncol. 2016;55(2):208-216.
Deng X, Michaelson D, Tchieu J, Cheng J, Rothenstein D, Feldman R et al. Targeting Homologous Recombination in Notch-Driven C. elegans Stem Cell and Human Tumors. PLoS One. 2015;10(6):e0127862.
Dasgupta T, Rothenstein D et al. Intensity Modulated Radiotherapy vs. Conventional Radiotherapy in the Treatment of Anal Squamous Cell Carcinoma: A Propensity Score Analysis. Radiother Oncol. 2013;107(2):184-94.